Hepatoselective carrier-mediated sodium-independent uptake of pravastatin and pravastatin-lactone

Ziegler, K. ; Hummelsiep, S.

Amsterdam : Elsevier
ISSN:
0005-2736
Keywords:
(Rat) ; Bile acid ; HMG-CoA reductase inhibitor ; Liver ; Pravastatin ; Transport
Source:
Elsevier Journal Backfiles on ScienceDirect 1907 - 2002
Topics:
Biology
Chemistry and Pharmacology
Medicine
Physics
Type of Medium:
Electronic Resource
URL:
_version_ 1798292199195017216
autor Ziegler, K.
Hummelsiep, S.
autorsonst Ziegler, K.
Hummelsiep, S.
book_url http://linkinghub.elsevier.com/retrieve/pii/0005-2736(93)90272-2
datenlieferant nat_lic_papers
fussnote Pravastatin and pravastatin-lactone are not taken up into extrahepatic cells such as fibroblasts, or hepatoma cells such as AS-30D ascites hepatoma cells or FAO cells. In contrast, pravastatin is taken up into isolated rat hepatocytes by a carrier mediated, saturable, temperature-dependent and energy-dependent mechanism. The kinetic parameters for the saturable uptake are K"m 27 μM, V"m"a"x 537 pmol/mg per min. The permeability coefficients were determined to be 9.829.10-^7 cm/s at 4^oC, 1.76.10-^6 cm/s at 7^oC, 3.85.10-^6 cm/s at 17^oC and if5.82.10-^6 cm/s at 37^oC. The activation energy is 60 KJ/mol for 100 μM pravastatin at 37^oC. The Q"1"0 values are between 1.7 and 2.8. In the presence of metabolic inhibitors and in the absence of oxygen, transport is inhibited. Uptake of pravastatin is not dependent on an extracellular to intracellular sodium-gradient. Replacement of chloride by sulfate, nitrate, gluconate or thiocyanate significantly inhibits the uptake of pravastatin. Uptake is competitively inhibited by cholate and taurocholate in the presence and absence of sodium. Pravastatin, however, competitively inhibits the uptake of cholate and taurocholate only in the absence of sodium. In addition, pravastatin-lactone enters liver cells via an energy-dependent, carrier-mediated uptake system. For the saturable energy-dependent part of the hepatocellular uptake a K"m value of 9 μM and a V"m"a"x value of 621 pmol/mg per min was determined. The permeability coefficient of pravastatin-lactone uptake is calculated to be 5.41.10-^6 cm/s at 37^oC. The uptake of pravastatin-lactone is competitively-noncompetitively inhibited by pravastatin and by lovastatin and vice versa. These results indicate that the hepatoselectivity of pravastatin is due to its carrier-mediated uptake into rat hepatocytes via a sodium-independent bile acid carrier. Pravastatin-lactone resembles pravastatin-sodium in its hepatoselectivity.
hauptsatz hsatz_simple
identnr NLZ185723691
iqvoc_descriptor_keyword iqvoc_00000124:Transport
issn 0005-2736
journal_name Biochimica et Biophysica Acta (BBA)/Biomembranes
materialart 1
package_name Elsevier
publikationsort Amsterdam
publisher Elsevier
reference 1153 (1993), S. 23-33
schlagwort (Rat)
Bile acid
HMG-CoA reductase inhibitor
Liver
Pravastatin
Transport
search_space articles
shingle_author_1 Ziegler, K.
Hummelsiep, S.
shingle_author_2 Ziegler, K.
Hummelsiep, S.
shingle_author_3 Ziegler, K.
Hummelsiep, S.
shingle_author_4 Ziegler, K.
Hummelsiep, S.
shingle_catch_all_1 Ziegler, K.
Hummelsiep, S.
Hepatoselective carrier-mediated sodium-independent uptake of pravastatin and pravastatin-lactone
(Rat)
Bile acid
HMG-CoA reductase inhibitor
Liver
Pravastatin
Transport
(Rat)
Bile acid
HMG-CoA reductase inhibitor
Liver
Pravastatin
Transport
0005-2736
00052736
Elsevier
shingle_catch_all_2 Ziegler, K.
Hummelsiep, S.
Hepatoselective carrier-mediated sodium-independent uptake of pravastatin and pravastatin-lactone
(Rat)
Bile acid
HMG-CoA reductase inhibitor
Liver
Pravastatin
Transport
(Rat)
Bile acid
HMG-CoA reductase inhibitor
Liver
Pravastatin
Transport
0005-2736
00052736
Elsevier
shingle_catch_all_3 Ziegler, K.
Hummelsiep, S.
Hepatoselective carrier-mediated sodium-independent uptake of pravastatin and pravastatin-lactone
(Rat)
Bile acid
HMG-CoA reductase inhibitor
Liver
Pravastatin
Transport
(Rat)
Bile acid
HMG-CoA reductase inhibitor
Liver
Pravastatin
Transport
0005-2736
00052736
Elsevier
shingle_catch_all_4 Ziegler, K.
Hummelsiep, S.
Hepatoselective carrier-mediated sodium-independent uptake of pravastatin and pravastatin-lactone
(Rat)
Bile acid
HMG-CoA reductase inhibitor
Liver
Pravastatin
Transport
(Rat)
Bile acid
HMG-CoA reductase inhibitor
Liver
Pravastatin
Transport
0005-2736
00052736
Elsevier
shingle_title_1 Hepatoselective carrier-mediated sodium-independent uptake of pravastatin and pravastatin-lactone
shingle_title_2 Hepatoselective carrier-mediated sodium-independent uptake of pravastatin and pravastatin-lactone
shingle_title_3 Hepatoselective carrier-mediated sodium-independent uptake of pravastatin and pravastatin-lactone
shingle_title_4 Hepatoselective carrier-mediated sodium-independent uptake of pravastatin and pravastatin-lactone
sigel_instance_filter dkfz
geomar
wilbert
ipn
albert
fhp
source_archive Elsevier Journal Backfiles on ScienceDirect 1907 - 2002
timestamp 2024-05-06T08:44:43.620Z
titel Hepatoselective carrier-mediated sodium-independent uptake of pravastatin and pravastatin-lactone
titel_suche Hepatoselective carrier-mediated sodium-independent uptake of pravastatin and pravastatin-lactone
Pravastatin and pravastatin-lactone are not taken up into extrahepatic cells such as fibroblasts, or hepatoma cells such as AS-30D ascites hepatoma cells or FAO cells. In contrast, pravastatin is taken up into isolated rat hepatocytes by a carrier mediated, saturable, temperature-dependent and energy-dependent mechanism. The kinetic parameters for the saturable uptake are K"m 27 μM, V"m"a"x 537 pmol/mg per min. The permeability coefficients were determined to be 9.829.10-^7 cm/s at 4^oC, 1.76.10-^6 cm/s at 7^oC, 3.85.10-^6 cm/s at 17^oC and if5.82.10-^6 cm/s at 37^oC. The activation energy is 60 KJ/mol for 100 μM pravastatin at 37^oC. The Q"1"0 values are between 1.7 and 2.8. In the presence of metabolic inhibitors and in the absence of oxygen, transport is inhibited. Uptake of pravastatin is not dependent on an extracellular to intracellular sodium-gradient. Replacement of chloride by sulfate, nitrate, gluconate or thiocyanate significantly inhibits the uptake of pravastatin. Uptake is competitively inhibited by cholate and taurocholate in the presence and absence of sodium. Pravastatin, however, competitively inhibits the uptake of cholate and taurocholate only in the absence of sodium. In addition, pravastatin-lactone enters liver cells via an energy-dependent, carrier-mediated uptake system. For the saturable energy-dependent part of the hepatocellular uptake a K"m value of 9 μM and a V"m"a"x value of 621 pmol/mg per min was determined. The permeability coefficient of pravastatin-lactone uptake is calculated to be 5.41.10-^6 cm/s at 37^oC. The uptake of pravastatin-lactone is competitively-noncompetitively inhibited by pravastatin and by lovastatin and vice versa. These results indicate that the hepatoselectivity of pravastatin is due to its carrier-mediated uptake into rat hepatocytes via a sodium-independent bile acid carrier. Pravastatin-lactone resembles pravastatin-sodium in its hepatoselectivity.
topic W
V
WW-YZ
U
uid nat_lic_papers_NLZ185723691